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Abstract: Bacteria make use of compartmentalizing pro-
tease complexes, similar in architecture but not homolo-
gous to the eukaryotic proteasome, for the selective and 
processive removal of proteins. Mycobacteria as members 
of the actinobacteria harbor proteasomes in addition to the 
canonical bacterial degradation complexes. Mycobacterial 
proteasomal degradation, although not essential during 
normal growth, becomes critical for survival under partic-
ular environmental conditions, like, for example, during 
persistence of the pathogenic Mycobacterium tuberculosis 
in host macrophages or of environmental mycobacteria 
under starvation. Recruitment of protein substrates for pro-
teasomal degradation is usually mediated by pupylation, 
the post-translational modification of lysine side chains 
with the prokaryotic ubiquitin-like protein Pup. This sub-
strate recruitment strategy is functionally reminiscent of 
ubiquitination in eukaryotes, but is the result of conver-
gent evolution, relying on chemically and structurally dis-
tinct enzymes. Pupylated substrates are recognized by the 
ATP-dependent proteasomal regulator Mpa that associates 
with the 20S proteasome core. A pupylation-independent 
proteasome degradation pathway has recently been dis-
covered that is mediated by the ATP-independent bacterial 
proteasome activator Bpa (also referred to as PafE), and 
that appears to play a role under stress conditions. In this 
review, mechanistic principles of bacterial proteasomal 
degradation are discussed and compared with functionally 
related elements of the eukaryotic ubiquitin-proteasome 
system. Special attention is given to an understanding on 
the molecular level based on structural and biochemical 
analysis. Wherever available, discussion of in vivo studies 
is included to highlight the biological significance of this 
unusual bacterial degradation pathway.
Keywords: mycobacteria; mycobacterial proteasomal 
ATPase Mpa; proteasomal activator Bpa (PafE); protea-
some; pupylation.
Introduction
The genus Mycobacteria encompasses  > 100 different 
species, which mostly exist as free-living organisms in soil 
and marshes, where they face rapidly changing conditions 
in terms of nutrient and oxygen availability (1, 2). The patho-
genic members, like, for example, Mycobacterium tuberculo-
sis and Mycobacterium leprae, have to persist in the hostile 
intraphagosomal environment of the host (3). As a conse-
quence, mycobacteria have to be highly adaptable and meta-
bolically flexible. Protein degradation plays a critical role in 
mounting a rapid and effective response to these challenges.
In eukaryotic cells, protein removal can be medi-
ated either by autophagy in combination with lysosomal 
degradation or by recruitment to the cylinder-shaped 
protease complex referred to as the proteasome, where 
compartmentalization is achieved inside a proteinaceous 
chamber (4, 5).
As bacteria are lacking the option of sorting proteins 
into separate organelles, they rely exclusively on compart-
mentalizing protease complexes that are non-homologous 
yet similar in architecture to the eukaryotic proteasome 
(6). Among these canonical protease complexes are the 
Clp proteases, the Lon protease, and the membrane-
anchored FtsH protease (Figure  1). Homologs of these 
typical bacterial proteases can also be found in eukaryotic 
compartments of endosymbiotic origin, namely mitochon-
dria and chloroplasts (Figure 1). All mycobacteria possess 
the modular Clp proteases, which are (with the exception 
of Mycoplasma) universal in bacteria. These consist of 
the ClpP protease cylinder that is associated with either 
the ClpC or the ClpX ATPase partner to form a fully active 
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protease complex (Figure 1) (6). Like all bacteria, myco-
bacteria also possess the membrane-associated FtsH 
protease capable of degrading cytosolic and membrane 
proteins. Both the Clp proteases and FtsH are essential in 
mycobacteria (7). Surprisingly, in addition to these canoni-
cal bacterial compartmentalizing proteases, mycobacteria 
and many other actinobacteria possess a proteasome (8), 
the main cytosolic degradation complex in eukaryotes, 
which is usually absent in bacteria. Although not essen-
tial under standard culture conditions (9), the proteasome 
is maintained in all mycobacteria (8), indicating that it 
is important for survival under particular environmental 
conditions. In cooperation with the ATP-dependent Mpa 
ring-complex, it recruits proteins that have been cova-
lently modified with prokaryotic, ubiquitin-like protein 
Pup in a process called pupylation (10, 11). A pupylation-
independent proteasome degradation route also exists in 
these bacteria, which is mediated by the bacterial protea-
some activator Bpa (also referred to as PafE) (12, 13).
In this review, we summarize the mechanistic prin-
ciples of proteasomal protein degradation in mycobacte-
ria and discuss its cellular function in the context of the 
bacteria’s life style. Furthermore, we draw parallels to the 
eukaryotic proteasome system, including the modes of 
substrate recruitment, and highlight similarities and fun-
damental differences.
The mycobacterial proteasome – 
an added eukaryotic-like feature
In all three domains of life, nature has evolved a multi-
tude of high-molecular weight, multisubunit proteolytic 
complexes that accomplish the removal of non-func-
tional, damaged or misfolded proteins, or proteins that 
are needed in the cell only for a limited amount of time 
(14). The major player in eukaryotic protein turnover is the 
26S proteasome (15) (Figure 1). It comprises two functional 
elements: the 19S regulatory particle (19S RP) and the 20S 
core particle (20S CP) (5). The latter is composed of seven 
distinct α and β subunits that form heptameric rings 
(α1–7/β1–7), respectively (16). These rings are stacked in an 
αββα order, resulting in the barrel-shaped appearance of 
Figure 1: Compartmentalizing proteases of Mycobacterium tuberculosis and their eukaryotic counterparts.
Compartmentalizing protease complexes comprise a core cylinder (light blue), enclosing the proteolytic active sites (red), that associates 
with energy-dependent (orange) or energy-independent (violet) regulatory ring-complexes to form the fully active protease. Mtb has the 
canonical bacterial degradation systems, -the cytosolic Clp proteases and the membrane-associated FtsH protease-, homologs of which can 
also be found in eukaryotic mitochondria. The main eukaryotic degradation machine is the 26S proteasome, built of the 20S core particle 
(20S CP) and the 19S regulatory particle ATPase (orange) and non-ATPase (pink) subunits. Unusual for the bacterial kingdom, Mtb harbors a 
proteasome complex in addition to the canonical bacterial degradation machines. This bacterial proteasome, found predominantly in the act-
inobacterial phylum and a few members of nitrospirae and verrucomicrobae, is of simpler subunit composition than its eukaryotic homolog.
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the 20S CP. The β-rings contain the proteolytically active 
subunits of the complex, featuring the N-terminal threo-
nine hydrolase sites, whereas the α-subunits provide the 
interface for interaction with the 19S RP and alternative 
regulators of the 20S CP (17). The 19S RP is a multisubu-
nit complex that combines several functions related to the 
recognition of poly-ubiquitinated substrates, ubiquitin-
chain processing, substrate unfolding, and the transloca-
tion of unfolded polypeptides to the proteolytic core of the 
proteasome (18–20).
First indications for the presence of an ATP-depend-
ent proteolytic activity in eukaryotes that is mediated by 
a complex protease were found nearly four decades ago 
(21, 22). The efforts of various groups were dedicated to 
the characterization and isolation of this activity [e.g. 
refs. (22–26)], finally resulting in the purification of the 
first eukaryotic 26S proteasome complex (27). Initially 
thought to be restricted to eukaryotes, the discovery of a 
20S CP in the archaeon Thermoplasma acidophilum put 
an end to this notion (28). The earliest indications of a 
bacterial proteasome derived from a study with nitrogen-
fixing Frankia (29). A high-molecular-weight protease, 
partially purified from the bacterium, largely resembled 
the eukaryotic 20S CP in shape and size as judged by 
electron microscopy, and exhibited cross-reactivity with 
an antiserum against eukaryotic proteasome. By compre-
hensive database searches and by an increasing amount 
of genome data available, the presence of genes coding 
for the α- and β-subunits of the 20S CP was confirmed in 
various bacterial species (9, 30–33). In contrast to eukary-
otes, bacterial and archaeal genomes encode only one or 
two α- and β-subunits. While the archaeal proteasome is 
generally considered to be the direct evolutionary precur-
sor of the eukaryotic proteasome, the existence of a 20S CP 
in bacteria remained puzzling. The occurrence of a bacte-
rial 20S CP is predominantly associated with the phylum 
Actinobacteria, a heterogeneous group of high-GC, 
Gram-positive bacteria (34). Likely adopted by horizontal 
gene transfer, the reasons why an additional proteolytic 
machinery was established in these bacteria next to the 
canonical bacterial ones remained unclear. As the genes 
coding for the proteasome appear to be mostly dispensa-
ble under standard growth conditions (9, 35), evolution 
most likely selected for it under special conditions, where 
survival could critically benefit from an additional com-
partmentalizing protease system (36). The identification 
of the proteasomal subunit genes – usually referred to as 
prcA and prcB – was eventually followed up by the char-
acterization of purified 20S CP from Rhodococcus erythro-
polis (32), Streptomyces coelicolor (37), and Frankia (38). A 
few sporadic members outside the actinobacterial phylum 
also harbor proteasomes, possibly as a result of secondary 
gene transfer from actinobacteria (33, 39, 40).
Investigations of the mycobacterial proteasomal deg-
radation system were initiated by a study in Mycobacte-
rium smegmatis (Msm) (9). Expression of a functional 
proteasome was strongly supported by the observation 
that lysates of an Msm ΔprcB strain displayed a 95% 
decrease in degradation activity for the proteasomal 
model peptide substrate succinyl-Leu-Leu-Val-Tyr-AMC. 
Accordingly, turnover of Suc-LLVY-AMC in Msm wild-
type-derived lysates could be inhibited by the proteasome 
inhibitor N-acetyl-Leu-Leu-norleucinal. These findings 
were corroborated by the identification of PrcA and PrcB 
in the proteome of Mycobacterium tuberculosis (Mtb) (41) 
and the presence of a proteasome inhibitor-sensitive pro-
teolytic activity in lysates of the bacterium (42).
Structure of the Mtb proteasome 
core particle
The crystal structure of the Mtb 20S CP revealed the 
canonical barrel-shaped overall architecture, highly 
reminiscent of eukaryotic and archaeal CPs (43, 44). The 
mycobacterial CP is constituted of a single type of both α- 
and β-subunits that form homoheptameric rings, which 
are arranged in the usual α7β7β7α7 order (Figure 1). This 
results in the formation of three chambers inside the CP 
cylinder that are connected with each other by pores. 
The central chamber, formed by the β-rings, harbors the 
active-site N-terminal threonine residues, sequestered 
from the cytosolic environment. Regarding the proteo-
lytic specificity, the 20S CP of Mtb differs from CPs found 
in other actinobacterial species. While the latter merely 
exhibit chymotryptic activity, the CP in Mtb additionally 
features tryptic and caspase-like activity (43). This broad 
substrate specificity is striking as it is accomplished by a 
single type of β-subunit. Eukaryotic 20S CPs harbor three 
distinct β-subunits, each dedicated to a specific activity 
(17). Analysis of the Mtb 20S CP substrate-binding pocket 
revealed a unique chimeric structure that joins elements 
found in the three eukaryotic proteolytically active 
β-subunits (43).
The α-rings, attached to either end of the central 
β-double ring, form the entrance pores to the 20S CP. To 
prevent unregulated degradation, access to the internal 
proteolytic chamber needs to be restricted. In eukaryotic 
20S complexes, the N-termini of the α-subunits interact 
with each other through a sequence motif containing a 
conserved tyrosine and aspartate residue, the YD motif, 
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thereby effectively sealing the 20S CP’s axial entrance 
pores (45). The deletion of seven N-terminal residues from 
the α-subunits leads to an open-gate CP with deregulated 
peptidase activity (45). Cryo-electron microscopy and 
structural analysis showed that the Mtb 20S CP is also a 
gated complex (44, 46). Although a YD-motif is absent, the 
α-subunit’s N-terminal residues are arranged such that 
the external pores are tightly sealed.
Although homologous to the β-subunits, both the 
eukaryotic and the bacterial α-subunits feature an addi-
tional N-terminal helix referred to as H0, that extends 
radially outward from the α-ring pore (16, 44, 47). The α-N-
termini are connected to this helix either directly (bacte-
rial 20S CP) or via a reverse turn element (eukaryotic 20S 
CP). In either case, gate closure is achieved by neighbor-
ing subunits adopting alternating conformations around 
the ring with respect to H0. In the Mtb 20S CP, six of the 
seven α-N-termini around the ring alternatingly feature an 
extended or L-shaped orientation with respect to H0, such 
that the hydrophobic stretches (Y5-F6-I7) in the L-shaped 
N-termini of three subunits around the ring stack on top 
of one another, blocking the gate (44). This is similar to 
the alternating conformations of the α-N-terminal tails 
preceding the reverse turn in the eukaryotic 20S CP, where 
three of the seven α-N-terminal strands point into the 
α-pore and interact through their YD-motifs, effectively 
closing the gate (47).
Assembly and maturation of the Mtb 
proteasome core particle
In eukaryotes, assembly of the 20S CP depends on struc-
tural features of the subunits and involves dedicated 
chaperones that support the correct arrangement of the 
heteroheptameric rings (17, 48). Orthologs of eukaryotic 
assembly factors have been identified in archaea and bac-
teria (49–51); yet, their exact physiological function needs 
to be scrutinized. Archaeal and bacterial 20S CPs readily 
assemble when expressed heterologously in Escheri-
chia coli (38, 46, 52–54). However, a prerequisite for Mtb 
and Rhodococcus 20S CP formation is the simultaneous 
expression of prcA and prcB. When expressed individu-
ally, α- and β-subunits fail to form heptameric rings (46, 
53). In contrast, α-subunits of Thermoplasma also oli-
gomerize in the absence of interacting β-subunits (52).
A common characteristic of bacterial and active 
eukaryotic β-subunits is an N-terminal pro-peptide that 
is present upon de novo synthesis and is autocatalyti-
cally removed to reveal the catalytic Thr1 residue. In the 
yeast proteasome, the pro-peptide was shown to prevent 
Na-acetylation of the active-site threonine residue until it 
is sequestered in the interior of the proteasome chamber 
(55). This protects Thr1 against inactivation, as the N-ter-
minal α-amino group plays an important role in accept-
ing a proton from the Thr hydroxyl to activate it for 
nucleophilic attack (55). A similar role could be played 
by the propeptides for the mycobacterial proteasome. 
CP assembly is finalized by autocatalytic removal of the 
β-subunit’s pro-peptides, which results in the exposure of 
the threonine residues and renders the complex proteo-
lytically active (56, 57). In eukaryotes and in Rhodococcus 
erythropolis, the β-subunit’s pro-peptides were shown to 
be crucial for the formation of the fully assembled 20S CP 
(53, 56, 58, 59). In contrast, Mtb and archaeal β-subunit 
pro-peptides are dispensable (46, 52). In fact, assembly of 
the Mtb 20s CP is slowed down by the pro-peptides. Due to 
their outward-facing conformation in half-proteasomes, 
they possibly hamper the association of two half-proteas-
ome particles (44). A recent study in Msm showed that 20S 
CP subunits are phosphorylated by the kinases PknA and 
PknB (60). Phosphorylation of the α-subunits by PknB 
results in an increase of the proteasome’s proteolytic 
activity. In contrast, PknA activity affects the assembly 
of the CP, acting on α-subunits as well as the pro-peptide 
bearing β-subunits in half-proteasomes. This apparently 
interferes with the apposition of two half-proteasomes 
and slows down the formation of fully processed mature 
20S CP.
Proteasome activators open 
the gates
The proteolytic core cylinders of compartmentalizing 
proteases (the 20S CP or the ClpP cylinder) are lined on 
their inner walls with the hydrolytic active sites (61–63) 
(Figure 1). In addition to compartmentalization, however, 
selectivity of access to the proteolytic chamber is required 
to prevent random proteolysis of cytosolic proteins. Pro-
teasomal core cylinders are therefore gated and require 
association with additional interactors that switch the 
conformation of the α-subunit’s N-termini to an open 
conformation (47, 64–67). In keeping with the principle 
of ring-stacking architecture, interaction partners of the 
proteasome are themselves ring-shaped, multisubunit 
assemblies that associate with the 20S CP α-rings coaxi-
ally, thereby roughly aligning their ring pore with the CP’s 
axial entrance pore (18, 64, 68) (Figure 1). Proteasome 
interactors, also referred to as regulators or activators, 
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serve not only to open the gate, but they also play impor-
tant roles in substrate recruitment.
A common principle for the interaction between 
the 20S CP and the gate-opening regulators has been 
observed (Figure  2A). The very C-terminal tails of the 
regulator subunits dock into binding pockets between 
adjacent α-subunits of the 20S CP, supporting a conforma-
tional change in the α-N-termini, which eventually results 
in gate opening (47, 64, 69, 70). For eukaryotic 20S CPs, 
this presumably involves direct or indirect contact of the 
C-terminal tails with the reverse turn following the α-N-
terminal strand of the 20S CP containing the YD-motif (71). 
While the identity of the C-terminal residue in the C-ter-
minal tails of the proteasome interactors is usually not 
important, the two or three residues preceding the termi-
nal amino acid confer specificity. Many of the regulators 
(e.g. eukaryotic 19S ATPases, eukaryotic PA200, eukary-
otic Cdc48, and archaeal proteasomal ATPases) (72), but 
not all (PA26) (47), possess a conserved penultimate tyros-
ine residue (sometimes also phenylalanine) preceded by 
Figure 2: Mycobacterial proteasomal activators and their mode of action.
(A) The energy-dependent Mpa and energy-independent Bpa complexes interact with the 20S core particle by docking into binding pockets 
of the core particle using a shared C-terminal GQYL motif. (B) The ATPase Mpa recognizes pupylated substrates (brown) by binding the 
covalently attached Pup (red) to its N-terminal coiled-coil domains forming a shared coiled-coil. The N-terminal region of Pup interacts with 
translocation loops (dark green) inside the Mpa pore. The loops undergo up and down movements in response to ATP hydrolysis leading to 
translocation through the pore and unfolding. The ATP-independent Bpa possibly only opens the proteasomal gate, allowing damaged, non-
native proteins to access the proteasomal core. Once in the core, protein chains are cleaved by the proteolytically active β-subunits.
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a hydrophobic residue, together referred to as the HbYX 
motif (69).
Some activators (e.g. PA26, Cdc48) employ an interac-
tion element in addition to the C-terminal tails to trigger 
gate opening, a so-called activation loop located on the 
20S CP-proximate face of the activator (47, 72). The loops 
are usually located at a smaller diameter position than the 
C-terminal tails and help open up the gates by pressing 
down on certain structural features of the α-N-termini. In 
case of the eukaryotic 20S CPs, this feature is again the 
reverse turn following the α-N-terminal strand. Although 
this reverse turn appears to be absent in bacterial 20S CPs, 
interactions of proteasome activator loops in a more axial 
position with the α-ring pore region of the 20S CP might 
nevertheless contribute to complex stabilization and gate 
opening here as well.
The mycobacterial proteasomal 
ATPase Mpa
Cellular proteins that have reached their native, folded, 
and fully assembled state do not gain access to the pro-
teolytic inner chamber of the 20S CP without being first 
processed by ATP-hydrolyzing proteasomal interactors 
(20). These generally ring-shaped ATP-dependent interac-
tors unfold recruited target proteins under the expense of 
energy and translocate them through their ring-pore into 
the proteolytic chamber, where degradation into small 
peptides takes place (14). In eukaryotes, the 19S regula-
tory particle (19S RP) associates with the 20S CP to from 
the 26S proteasome complex (5) (Figure 1). The 19S RP 
consists of a hexameric ring of ATPase subunits of the 
AAA type (Rpt1-6) and a number of non-ATPase subunits 
(Rpn1–13) involved in substrate recruitment and regula-
tion (18).
The mycobacterial 20S CP was shown to interact with 
an AAA (ATPases associated with various cellular activi-
ties) family protein referred to as mycobacterial proteaso-
mal ATPase (Mpa) (73), encoded upstream in the vicinity 
of the proteasomal α- and β-subunit genes. Mpa shows 
similarity in domain architecture to eukaryotic ATPase 
subunits (Rpts) (74). The large C-terminal AAA module 
forms the main ring structure that stacks to the 20S CP 
face via a C-terminal GQYL motif (Mpa) (Figure 2A) or the 
HbYX-motif (Rpts), both featuring the canonical aromatic 
residue in the penultimate position. This AAA domain is 
preceded by one (in Rpts) or two (in Mpa) oligonucleotide 
binding (OB-) domains, each adopting a five-stranded 
β-barrel fold. The OB-domains sit on top of the AAA ring, 
forming a single-tiered (Rpts) or two-tiered (Mpa) rigid 
neck. From the six OB-domains, three coiled-coil struc-
tures emerge that are built through the intertwining of 
N-terminal helical domains of neighboring subunits 
(Figure 1).
The eukaryotic 19S RP and Mpa also share the mecha-
nistic principle of substrate recognition. Proteasomal sub-
strate proteins in eukaryotes are recruited to the 19S RP 
by means of a post-translational small protein tag called 
ubiquitin (Ub) that is attached covalently to lysine side 
chains of the degradation target (75–78). Likewise, bac-
terial proteasome degradation targets are modified on 
lysine side chains with a small protein modifier referred 
to as Pup (prokaryotic ubiquitin-like protein) for its func-
tional analogy to Ub (10, 11). However, while the eukary-
otic and bacterial proteasomes are clearly homologous, 
the substrate recruitment strategy is a result of conver-
gent evolution. The bacterial Pup and eukaryotic Ub show 
no sequence or structural homology. Ub adopts a stable 
globular fold (β-grasp fold), whereas Pup is intrinsically 
disordered (79–82). As a consequence, the molecular 
mechanisms of recognition by their respective binding 
partners are also different. Both proteins are attached via 
their C-terminal residue to the ε-amino group of a lysine 
side chain in the target, forming an isopeptide bond (83–
85). In case of Ub, the C-terminal residue is a glycine and 
the bond is formed through the C-terminal carboxylate. 
The C-terminal residue of Pup that is attached to target 
lysines is a glutamate, and the bond is formed through the 
side-chain carboxylate (86). The machinery responsible 
for attaching the modifier to the target protein has evolved 
independently for ubiquitination and pupylation. There-
fore, the responsible enzymes exhibit no homology. The 
mechanism of pupylation will be discussed in detail in the 
subchapter on pupylation.
Both Pup and Ub are recognized by their respective 
regulatory particles, Mpa or the 19S complex (20, 68, 80, 
87). The 19S RP of the eukaryotic 26S proteasome recog-
nizes ubiquitinated substrates via dedicated non-ATPase 
subunits like Rpn13 and Rpn10 (88, 89). The homohexam-
eric Mpa recognizes Pup directly via the N-terminal coiled-
coil domains (Figure 2B) (80). Binding to Mpa induces 
the formation of a long helix in Pup residues 21–58 (of 
64 residues total) and arrangement into a three-helical 
shared coiled-coil with Pup in antiparallel orientation to 
the Mpa N-termini (80, 87). The N-terminal region of Pup 
remains unstructured and plays an important role in the 
initiation of unfolding by interacting with Mpa transloca-
tion loops located deeply in the Mpa pore (90) (Figure 2B). 
The ATP-driven up and down movement of these loops 
exerts a pulling force on the pupylated substrate, leading 
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to directional translocation into the pore and unfolding 
(Figure 2B). Ub, on the other hand, does not include the 
translocation initiation module, and the ubiquitinated 
substrate must feature a loose N- or C-terminal region 
or extended loop to be successfully pulled into the pro-
teasomal core (91, 92). Ub is not translocated into the 
20S CP but is cleaved off and thereby recycled. Pup, on 
the other hand, serving as a threading handle, is conse-
quently degraded along with the substrate in vitro (90). 
It remains to be seen if additional mechanisms present in 
vivo might act to prevent this co-degradation. It has been 
hypothesized that the depupylase Dop (discussed later in 
this review) could play a role in such a scenario in vivo 
(93), but  no conclusive evidence is available to date to 
support this.
The ATP-independent bacterial 
 proteasome activator Bpa
The modular interaction between a cylinder-shaped pro-
teolytic core and alternative toroidal interaction partners 
is a common principle observed for both the bacterial Clp 
proteases and the eukaryotic proteasome (Figure 1) (94). 
Interestingly, energy-independent proteasome activators 
(PA complexes) exist in eukaryotes (66), for example the 
PA28 (11S) (95, 96) and the PA200 complex (97), leading to 
the formation of ATP-independent PA-20S CP complexes 
(Figure 1). No such interactors were known for the bacte-
rial proteasome thus far.
Now, a recent report describes the discovery of a 
novel ring-shaped bacterial proteasome activator termed 
Bpa that is shown by electron microscopy (EM) to associ-
ate coaxially with the 20S CP (12). Top views of Bpa alone 
present in negative-stain EM micrographs with a ring-
shaped topology of roughly 6- or 7-fold symmetry or pseu-
dosymmtery and a central stain-filled opening. While gel 
filtration analysis suggests a possible hexameric or hepta-
meric assembly state, an independent study also describ-
ing the discovery of Bpa (referred to as PafE in that study) 
suggests a ring with 12 subunits based on size exclusion 
chromatography with multiangle light-scattering analy-
sis (13). The exact oligomeric state of Bpa and arrange-
ment around the central axis awaits further structural 
characterization.
Interestingly, Bpa and Mpa share the C-terminal inter-
action motif (both Mtb proteasome interactors end in the 
sequence GQYL) and are expected to use the same mode 
of interaction with the 20S CP, inserting the C-termini 
into binding pockets on the α-rings of the CP, leading to a 
rearrangement of the α-N-termini and thereby opening of 
the proteasomal gate (Figure 2A) (12, 13). Bpa can compete 
with Mpa for binding to the proteasome in vitro, efficiently 
inhibiting the degradation of pupylated substrates by the 
Mpa-proteasome complex (12). However, in vivo competi-
tion is unlikely, as quantitative mass spectrometric analy-
sis of the Mtb proteome detected protein levels equivalent 
to roughly 3-fold more 20S CP compared to Mpa ATPase 
rings under standard culture conditions (98), allow-
ing formation of both Bpa- and Mpa-proteasome com-
plexes simultaneously. The ability of the Bpa-proteasome 
complex to stimulate the degradation of an unstructured 
model substrate suggests a role in the removal of non-
native, damaged proteins under stress (12). This notion 
is further supported by the fact that a mutant Mtb strain 
deficient in bpa (pafE) only exhibits a slight growth defect 
in liquid standard culture, but under more stringent 
conditions (solid culture) or in a mouse infection model 
shows more severe growth phenotypes (13). Interestingly, 
heat shock repressor HspR accumulates in the bpa-defi-
cient strain and serves as a degradation substrate of the 
Bpa-proteasome complex in vitro (13). Stimulating the 
expression of HspR-repressed chaperones Hsp70 and ClpB 
by degradation of HspR while at the same time removing 
damaged, unstructured proteins, would combat proteo-
stasis stress on two fronts.
The discovery of Bpa has provided yet another paral-
lel between the bacterial and the eukaryotic proteasomal 
degradation systems (12, 13). Both feature two distinct 
degradation routes to the proteasome; an ATP-depend-
ent route mediated by recruitment via ubiquitination or 
pupylation, respectively; and an ATP-independent route 
that is not mediated by a small protein modifier tag 
(Figure 2B).
Pupylation – Pup ligase applies 
the mark of death
Recruitment of substrate proteins for degradation by the 
Mpa-CP complex relies on their post-translational modifi-
cation with the small protein Pup (10, 11). The attachment 
to lysine side chains and the function as a recognition 
signal for the proteasome complex underscores the 
similarity to eukaryotic ubiquitination (75). However, 
pupylation and ubiquitination are biochemically dis-
tinct processes that have evolutionarily converged to 
perform related functional roles. Pupylation is mediated 
by enzymes unrelated to the E1, E2, and E3 cascade of 
enzymes involved in ubiquitination (33, 99–101). A single 
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enzyme, the Pup ligase PafA encoded in the Pup-protea-
some gene locus, is responsible for the modification of 
all pupylation targets, and combines the activating, con-
jugating, and ligating activities in one active site (101). 
While wild-type Mtb shows a dense ladder of pupylated 
substrates in polyacrylamide gel electrophoresis fol-
lowed by blotting with anti-Pup antibody, pupylated 
substrates are undetectable in a pafA-deficient Mtb strain 
(10, 102). Structural analysis (103, 104) showed that PafA 
is composed of a large N-terminal domain of about 400 
residues that is structurally homologous to the carboxy-
late-amine ligase superfamily. Tightly associated with it 
is the much smaller C-terminal domain of about 70 resi-
dues (Figure  3). This smaller domain is not present in 
other members of the carboxylate-amine ligase family, 
but is unique to the pupylation enzymes. The active site 
is contained mostly in the N-terminal domain. It consists 
of an antiparallel, concave β-sheet with the ATP-binding 
site located at the end of the sheet that makes contact 
with the C-terminal domain, which together with loops 
emanating from the β-strands effectively closes off the 
β-sheet cradle from that side. The tri-phosphate chain 
of ATP extends along the β-strands toward the opposite, 
accessible end of the sheet. The co-crystal structure of 
PafA with Pup (103) (Figure 3) shows that the C-terminal 
glutamate of Pup binds at the accessible end of the sheet 
with the γ-carboxylate positioned for phosphoryl trans-
fer from ATP (Figures 3 and 4A). Leading away from the 
β-sheet cradle is a roughly 50 Å long groove lined by con-
served residues. The C-terminal half of Pup binds into the 
groove by adopting a structure of two orthogonal helices 
connected by a short linker (103) (Figure 3). Exiting from 
the active site cradle, Pup wraps around to the ‘backside’ 
of PafA, presumably to prevent intramolecular attack by 
a lysine in the flexible N-terminal region of Pup that does 
not participate in the binding.
In the first step of the PafA-catalyzed reaction, the 
γ-glutamyl carboxylate at the Pup C-terminus is activated 
by phosphoryl transfer of the γ-phosphate from ATP, 
forming the mixed acyl-phosphate anhydride intermedi-
ate of Pup (105) (Figure 4A). This step is equivalent to the 
adenylylation of Ub by the E1-activating enzyme (106). In a 
second step, the target protein must bind to PafA in such a 
way that the ε-amino group of the lysine side chain is close 
to the activated γ-carboxylate of Pup and that the ε-amino 
group can furthermore be activated by the catalytic base, 
a strictly conserved aspartate residue in the loop between 
β-strands 3 and 4 of PafA (104). Nucleophilic attack of 
the lysine ε-amino group on the γ-carbonyl carbon of the 
mixed anhydride of Pup then leads to formation of the iso-
peptide bond (Figure 4A).
Bioinformatic analysis suggests that the Pup ligase 
PafA originated from an ancestral glutamine synthetase 
enzyme and has maintained the overall fold of the active 
site including the concave β-sheet cradle with the GhExE 
(where ‘h’ denotes a hydrophobic residue and ‘x’ any 
amino acid residue) Mg2+-ATP-binding motif in strand 1 
(51, 107). This motif forms part of the nucleotide binding 
site in the active site of all carboxylate-amine superfam-
ily members, to which belong, for example, glutamine 
synthetases (GS) and their evolutionary descendants, 
γ-glutamylcysteine ligases (GCL), that are involved in 
glutathione biosynthesis. The two conserved glutamate 
residues emanating from strand 1, which is located at 
the center of the β-sheet, coordinate several Mg2+ ions in 
complex with the ATP phosphate groups. Both GS and 
GCL members catalyze two-step reactions with phospho-
rylation of the γ-carboxylate group of glutamate (107). This 
underlines the fact that the chemistry of the reaction cata-
lyzed by PafA or during the synthesis of glutamine from 
glutamate is maintained: the γ-carboxylate of a glutamate 
is activated by phosphoryl transfer and then reacts with 
an amine forming a C-N bond. The evolution of the Pup 
ligase likely was also driven by the nature of its substrates. 
The enzyme had to change in such a way that instead of 
small molecules (glutamate and ammonia), macromol-
ecules, which are available at much lower concentrations, 
can serve as substrates, namely Pup with its C-terminal 
glutamate and the target protein’s lysine side chain. As a 
consequence, the active site in the Pup ligase has to be 
more accessible to accommodate a broad range of target 
proteins, some of which occur as components of even 
larger oligomeric complexes. Furthermore, binding con-
tacts have to extend beyond the reacting groups to ensure 
high enough affinity for efficient binding. Concurrent with 
these requirements, Pup ligase PafA features a shallow 
and broad active site that can easily be approached by 
large substrates (103). The binding groove of Pup provides 
an interface area of  > 1500 Å2, allowing for a dissociation 
constant for Pup in the low micromolar range (103, 104).
Depupylation – mycobacteria have 
built-in rescue
Interestingly, the Pup-proteasome gene locus encodes for 
another glutamine synthetase homolog that furthermore 
exhibits high sequence and structural similarity to PafA 
(33, 101). In fact, it was originally hypothesized that PafA 
ligase might act as a heterodimer (51). However, despite 
the fact that this gene (dop) also encodes a glutamine 
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synthetase homolog and its disruption in Mtb or Msm 
abolishes all pupylation activity, it does not catalyze the 
ligation reaction between Pup and the target proteins 
(93, 101, 108). Intriguingly, all mycobacteria encode Pup 
with a C-terminal glutamine instead of glutamate. Yet, 
analysis of pupylated substrates by mass spectrometry 
consistently detected a 1-Da difference between the calcu-
lated and the theoretical mass of Pup-modified peptides, 
proving that it is a glutamate and not a glutamine that is 
present in the conjugate (10). In vitro biochemical char-
acterization of the PafA homolog Dop demonstrated that 
it converts PupQ into the ligation-competent PupE, acting 
as a deamidase (94). Thus, for pupylation to take place in 
mycobacteria, the sequential action of both Dop and PafA 
is required. However, deamidation is not the only activity 
of Dop. Its ability to cleave the covalent bond between a 
carbonyl carbon and amide nitrogen extends to the iso-
peptide bond in pupylated substrates (109, 110). At first 
glance paradoxical, Dop, a close structural homolog of the 
Pup ligase PafA, acts as the antagonist of pupylation by 
removing Pup from pupylated substrates (Figure 4A and 
B). This depupylase activity of Dop makes the pupylation 
pathway reversible and echoes the activity of the deubiq-
uitinating enzymes in the ubiquitin-proteasome system. 
At second glance, the fact that the depupylase has the 
same fold and evolutionary origin as the Pup ligase PafA 
is not that surprising, as both need to feature binding sur-
faces for Pup and the target protein, and both catalyze 
the nucleophilic attack on a carbonyl carbon with either 
the lysine side chain (PafA) or water (Dop) acting as the 
Figure 3: Crystal structure of the complex between Pup and the ligase PafA.
PafA is composed of a larger N-terminal domain of about 400 residues (dark blue) and a smaller C-terminal domain of about 70 residues 
(light blue). The active site comprises a concave β-sheet with ATP (yellow) bound at one end of the sheet and the C-terminal residue of Pup 
(red) bound at the opposite end. The γ-carboxylate of Pup’s C-terminal glutamate (highlighted by a dashed white circle) is positioned for 
phosphoryl transfer from ATP. The C-terminal half of Pup binds into a long, conserved groove, leading away from the β-sheet cradle and 
wrapping Pup around to the opposite side of the PafA monomer. Upon binding, the intrinsically disordered Pup folds into two orthogonal 
helices connected by a short linker.
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nucleophile (Figure 4A). In fact, Dop features a very similar 
binding groove leading into the active site β-sheet cradle, 
suggesting that it interacts with Pup according to a similar 
mechanism (104). An aspartate residue that is strictly con-
served in both PafA and Dop members could play a role in 
supporting the nucleophilic attack on the carbonyl carbon 
in either enzyme (104). Alternatively, during the reaction 
cycle of Dop, this aspartate might even directly act as the 
nucleophile, leading to the transient formation of a cova-
lent intermediate with Pup (111).
It is interesting to mention that Pup is not always 
encoded with a C-terminal glutamine, but that many 
Figure 4: The pupylation-depupylation cycle.
(A) The PafA-catalyzed pupylation reaction occurs in two steps. In the first step, the C-terminal γ-glutamyl carboxylate of Pup is activated by 
phosphoryl transfer from ATP, resulting in formation of a mixed anhydride. In the second step, the isopeptide bond between the substrate’s 
lysine and Pup is formed by a nucleophilic attack of the lysine ε-amino group on the γ-carbonyl carbon of the mixed anhydride of Pup. The 
isopeptide bond can be cleaved by Dop, a structural homolog of PafA. Dop catalyzes the nucleophilic attack of water on the carbonyl carbon 
of the isopeptide bond, thereby releasing Pup from the substrate. (B) Together, the two homologous enzymes PafA and Dop regulate the 
pupylation state of a protein via a pupylation-depupylation cycle.
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members of actinobacteria directly encode a glutamate. In 
those organisms, Dop is not required for pupylation to take 
place, as the deamidation step falls away. All mycobac-
teria, however, encode Pup with a C-terminal glutamine 
and, as a consequence, pupylated proteins are only gener-
ated when Dop is expressed. In other words, the depupy-
lase activity is built into the pupylation cycle by default. 
Presumably, this allows a tighter control on the amount of 
pupylation and the fraction of pupylated substrates enter-
ing into proteasomal degradation. For example, an Mtb 
dop knockout that is complemented with Pup carrying a 
C-terminal glutamate cannot maintain wild-type levels of 
pupylated substrates (93).
When the Pup-proteasome system 
becomes a matter of survival
Bacteria have evolved a plethora of mechanisms to resist 
even highly hostile and adverse environments. Their 
ability to respond and adapt quickly to changing growth 
conditions is the key to survival. After being phagocytosed 
by host macrophages in the lungs upon inhalation, Mtb, 
the causative agent of tuberculosis, is confronted with a 
massive immune response initiated to eradicate the path-
ogen (112, 113). However, Mtb is well equipped to evade 
elimination, so that only a fraction of the bacteria are 
killed. On the other hand, a healthy immune response also 
prevents proliferation of the surviving Mtb and thereby 
active disease in most cases. The result of this ‘stalemate’ 
between bacteria and host is the formation of a so-called 
latent state. By modulating important functions of the 
macrophage, the bacteria create a niche for survival that 
allows them to persist in the host for decades in a slow-
growing or dormant state that can, at any time, progress to 
active disease when host defenses are low (114–117).
Phagocytosis of Mtb results in formation of an orga-
nelle inside the macrophage referred to as the phago-
some, where Mtb is targeted by a range of host defense 
mechanisms including, among others, the production of 
reactive oxygen species and reactive nitrogen intermedi-
ates (RNIs) (118). An important step for Mtb toward persis-
tence is to survive the attacks by the various bactericidal 
effectors the pathogen is exposed to inside the phago-
some. Apart from that, Mtb employs mechanisms to block 
the fusion of the phagosome it resides in with lysosomes, 
the route by which phagocytosed bacteria are ultimately 
eliminated. The defense response in macrophages is gen-
erally triggered through immune-signaling proteins like, 
for example, interferon-γ (IFN-γ), which is released by 
activated T-cells in response to the presence of pathogens. 
Upon activation by IFN-γ, macrophages express an induc-
ible nitric oxide (NO) synthase, resulting in the generation 
of large amounts of NO and subsequently in the formation 
of other RNIs. RNIs damage bacteria by modifying their 
DNA, proteins, and membrane lipids (119–121). Though 
infections with Mtb can be curtailed by RNI formation, not 
all of the bacteria are finally eliminated, as Mtb has the 
capacity to resist nitrosative stress (119, 122).
The RNI resistance phenotype of Mtb was initially 
linked to the Pup-proteasome system in a screen of trans-
poson mutants that were found to be hypersensitive to 
nitrosative stress conditions in vitro (42). Therefore, it was 
hypothesized that proteasomal degradation functions in 
the removal of proteins damaged by nitrosylation. Inac-
tivation of the genes coding for the proteasomal chaper-
one Mpa and the Pup-ligase PafA sensitized Mtb to RNIs. 
Similar in vitro phenotypes were observed for mutants 
devoid of dop or that lack prcB and prcA, which code for 
the 20S CP (93, 123, 124). In accordance with these find-
ings, Mtb deficient in pupylation or proteasomal degrada-
tion displayed attenuation of virulence in a mouse model 
of infection (42, 93, 102, 123–125). Somewhat surprisingly, 
complementation of Mtb ΔprcBA with genes coding for a 
proteolytically inactive variant of the 20S CP restored near 
wild-type levels of RNI resistance (123). The mechanism 
underlying this observation is not known. It was sug-
gested that the 20S CP might play a role in maintaining 
a certain stoichiometry of proteasomal factors that are 
bound to the proteasome versus those that occur freely in 
the cell. A disturbance of this balance might be detrimen-
tal for growth and hereby render the cell more susceptible 
to RNIs. However, despite the supportive function of the 
inactive proteasome under nitrosative stress, only a pro-
teolytically active 20S CP was found to promote long-term 
persistence and intracellular survival of Mtb (123).
Sensitization of Mtb for RNIs in the absence of a func-
tional Pup-proteasome system was recently attributed 
to cellular accumulation of a specific, newly identified 
pupylation target and proteasomal substrate, namely Log 
(Rv1205) (126). A detailed analysis revealed that Log is 
homologous to a plant enzyme that acts as a phosphori-
bosyl hydrolase and mediates the final step in cytokinin 
biosynthesis. Indeed, Mtb was also shown to produce 
cytokinins in a Log-dependent manner; yet, their physi-
ological function in the pathogen remains unknown. 
Deregulation of Log turnover in an Mtb Δmpa strain results 
in elevated levels of Log and therefore in increased forma-
tion of cytokinins. This, in turn, leads to the accumulation 
of cytokinin-derived metabolites, like para-hydroxyben-
zaldehyde. The excessive buildup of aldehydes in the cell 
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lastly sensitizes the bacteria for RNIs and kills them in a 
synergistic manner by a yet unknown mechanism (126).
It has become increasingly clear that conferring resist-
ance to RNIs is only one functional aspect of pupylation and 
proteasomal degradation in Mtb. This is evident from the 
observation that virulence of Mtb pafA and mpa mutants 
is nonetheless attenuated in mice that lack a functional 
IFN-γ inducible NO synthase (iNOS) (42, 102). Likewise, 
chemical inhibition of iNOS in mice resulted in severe 
attenuation of Mtb ΔprcBA (123). A far-reaching impact of 
the Pup-proteasome system is also implied by the broad 
range of proteins that were found to be pupylated in Mtb 
(127). The identified targets comprise numerous players 
involved in important metabolic pathways, protein turno-
ver, and virulence. Notably, not all proteins that are tagged 
with Pup are actually degraded (127). This observation 
leaves room to speculations regarding other, degradation-
independent functions of Pup, analogous to ubiquitin in 
eukaryotes. However, whether pupylation and proteaso-
mal degradation serve any specific regulatory purpose in 
connection with Mtb pathogenicity is not clear. In general, 
the adjustment and/or maintenance of cellular levels of 
various proteins appear to be distinct features of the Pup-
proteasome system in Mtb.
The impairment of Pup-dependent degradation also 
affects transcription of a large number of genes (128). 
Analysis of transcriptional changes occurring in mpa and 
pafA mutants of Mtb led to the discovery of the copper-
responsive RicR regulon, which was shown to promote 
resistance against toxic levels of copper and thus to con-
tribute to Mtb virulence (128, 129).
Despite the broad range of pupylation targets and 
the observed effects on the transcriptional level, deletion 
of, e.g. dop, mpa or prcBA in Mtb, results in no or only a 
relatively mild growth phenotype under standard in vitro 
conditions in liquid culture (92, 117, 119), indicating that 
proteasome-dependent turnover of pupylated proteins 
is largely dispensable in non-stress environments. Still, 
some differences exist between the different knockouts. 
For example, while deletion of Mtb dop resulted in no-
growth phenotype when grown in liquid standard growth 
medium (92), an Mtb mutant devoid of the proteasomal 
chaperone Mpa displayed an increased doubling time 
when grown in shaking cultures, and the cells exhibited a 
small colony phenotype on agar plates (119). Particularly 
when comparing the growth behavior on solid medium, 
phenotypes differ more severely. Deletion of the proteaso-
mal α- and β-subunit genes in Mtb results in only a mild 
growth phenotype in shaking liquid cultures; however, 
the same knockout strain shows strongly reduced growth 
on agar plates (117). Taken together, these observations 
indicate that despite their concerted action in the Pup-pro-
teasome system, the components involved in pupylation 
and especially those related to proteasomal degradation 
carry out additional functions in other pathways.
As described above, protein turnover by the 20S CP 
in Mtb is not restricted to pupylated substrates that are 
recognized and processed by Mpa. Discovery of the alter-
native 20S CP activator Bpa added a new facet to protea-
somal degradation and underlines its importance for Mtb 
physiology (12, 13). The impact of this additional branch of 
proteasome-mediated proteolysis is reflected by increased 
heat stress sensitivity of an Mtb bpa deletion mutant in 
vitro. In addition, the strain displayed significant attenua-
tion of virulence in mice (13).
Non-pathogenic mycobacteria differ from their obli-
gate pathogenic counterparts by their lifestyle, as they are 
mostly soil-dwelling saprophytic bacteria that are usually 
not associated with a host (130). Yet, the Pup-proteasome 
system is also conserved in these species, implying a func-
tion beyond virulence and pathogenicity. A recent study 
in Msm provided an interesting explanation for the role 
of pupylation and proteasome-mediated degradation in 
non-pathogenic mycobacteria (131). The Pup-proteasome 
system was shown to be important under starvation condi-
tions, especially when the availability of nitrogen is limited 
and cannot be assimilated anymore in sufficient amounts 
by common mechanisms. In order to compensate for the 
lack of nitrogen sources, the degradation of pupylated pro-
teins is then engaged to recycle amino acids, which eventu-
ally allows for the maintenance of basal cellular functions.
Accordingly, an Msm strain lacking both pup and 
prcBA was severely affected in its ability to survive nitro-
gen starvation. What remains puzzling, however, is the fact 
that reintroduction of pup in this mutant was sufficient to 
almost fully complement the phenotype, and complemen-
tation with only prcBA did not have any improving effect 
regarding survival under nitrogen limitation. It is conceiv-
able that pupylated proteins are degraded via other deg-
radation machineries that partially compensate for the 
absence of the proteasome. However, whether the relatively 
mild phenotype of the pup-only complementation can be 
explained by the minute decrease in levels of pupylated 
proteins indeed observed in an Msm ΔprcAB mutant under 
nitrogen limitation, remains to be further scrutinized.
Concluding remarks
Research on pupylation and proteasomal degradation 
is not in its infancy anymore. Exciting contributions by 
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various groups in recent years provided a broad under-
standing regarding mechanistic, functional, and structural 
features of the Pup-proteasome system. Still, important 
aspects remain elusive, like, for instance, substrate rec-
ognition by the Pup-ligase PafA or possible degradation-
independent functions of Pup, to name but a few.
In eukaryotes and archaea, the 20S CP constitutes the 
central component of various proteolytic systems, which 
differ by their respective proteasomal regulators (94, 132). 
This modular concept is a rather simple but efficient way 
to cover a wide range of various physiological functions 
related to the degradation of a multitude of different 
substrates. The discovery of the alternative proteasome 
activator Bpa added a similar level of complexity to pro-
teasomal degradation in prokaryotes (12, 13). Like Mpa, 
Bpa harbors a C-terminal GQYL motif, which is crucial for 
proteasomal gate opening (Figure 2A). Yet, it is tempting 
to speculate whether the spectrum of bacterial protea-
some regulators encompasses also members that mediate 
interaction by different C-terminal motifs or other struc-
tural determinants. The eukaryotic equivalent for such a 
case is the 11S particle, which features a C-terminal motif 
that is quite different from the HbYX-motif found in the 
eukaryotic Rpts (94).
There is a clear discrepancy between the apparently 
specific impact of Pup-dependent degradation on indi-
vidual pathways like Log-mediated cytokinin synthesis in 
Mtb and the rather unspecific function observed in Msm 
for amino acid recycling under nitrogen starvation con-
ditions, which results in seemingly undirected turnover 
of a plethora of proteins. Of course, it is conceivable that 
the Pup-proteasome system has different roles in differ-
ent species, and that it was adapted to the requirements 
of pathogenic or non-pathogenic life styles. The recently 
introduced recycling concept, however, was suggested to 
also hold true for Mtb in context of the prevailing short-
age of nutrients inside the macrophage (131). Against this 
background, the RNI-sensitive phenotype of Pup-protea-
some-deficient Mtb mutants appears to be an unspecific 
accidental consequence of failed degradation.
Apart from that, despite the clearly established link of 
Log-accumulation in Mtb deficient in proteasomal degra-
dation and increased RNI sensitivity (126), it is somewhat 
puzzling that the complementation of Mtb ΔprcBA with 
an inactive proteasome does reestablish wild-type RNI 
 resistance (123).
In recent years, the Mtb proteasome became the 
subject of investigations dedicated to the finding of spe-
cific inhibitors that could be applied as new anti-tuber-
culosis drugs (133–135). The growing numbers of cellular 
functions that can be attributed directly or indirectly to 
the activity of the mycobacterial proteasome underline 
why it is such an interesting and attractive target.
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